AR
Advisory Research’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,560
| Closed | -$348K | – | 195 |
|
|
2023
Q4 | $348K | Buy |
+5,560
| New | +$348K | 0.05% | 278 |
|
|
2021
Q3 | – | Sell |
-3,201
| Closed | -$518K | – | 368 |
|
|
2021
Q2 | $518K | Buy |
+3,201
| New | +$518K | 0.03% | 261 |
|
|
2021
Q1 | – | Sell |
-7,444
| Closed | -$1.14M | – | 351 |
|
|
2020
Q4 | $1.14M | Sell |
7,444
-6,171
| -45% | -$945K | 0.08% | 177 |
|
|
2020
Q3 | $1.14M | Sell |
13,615
-930
| -6% | -$77.8K | 0.11% | 163 |
|
|
2020
Q2 | $1.07M | Buy |
+14,545
| New | +$1.07M | 0.1% | 165 |
|